last day for compounded semaglutide 🚨 FDA Ends Shortage The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant Compounded Semaglutide Program: Results, Timeline

not an approved therapy

The clinical significance was highlighted by Lilly's leadership: "Obesity is a chronic, progressive disease, and sustaining weight loss remains a significant challenge for many," said Kenneth Custer , Ph.D., executive vice president and president, Lilly Cardiometabolic Health

The escalation intervals were not arbitrary: each step was separated by several weeks to allow for monitoring of adverse events, biomarker shifts, and weight-loss trends

The side effect profile of any GLP-1 patch would likely reflect both the systemic effects of GLP-1 receptor agonism (common to all delivery methods) and local effects specific to transdermal administration

Other common synonyms include NNC 26-0161 and Ibutamoren